Table 3. Complications in the newborns evaluated in this study.
| Variables | Total n = 63 | Case n = 21 | Control n = 42 | OR | 95% CI | p value |
|---|---|---|---|---|---|---|
| VDRL titer | 0.58 | 0.20-1.71 | 0.330 | |||
| ≤ 1:4 | 33 (52.4) | 13 (61.9) | 20 (47.6) | |||
| ≥ 1:8 | 30 (47.6) | 8 (38.1) | 22 (52.4) | |||
| Hospitalization | 49.99 | 6.02-415.29 | 0.003 | |||
| Yes | 32 (50.8) | 20 (95.2) | 12 (28.6) | |||
| No | 31 (49.2) | 1 (4.8) | 30 (71.4) | |||
| Symptomatic syphilis | 1.36 | 0.21-8.89 | 0.743 | |||
| Yes | 5 (7.9) | 2 (9.5) | 3 (7.1) | |||
| No | 58 (92.1) | 19 (90.5) | 39 (92.9) | |||
| Low birth weight | 4.06 | 0.86-19.04 | 0.075 | |||
| Yes | 8 (12.7) | 5 (23.8) | 3 (7.1) | |||
| No | 55 (87.3) | 16 (76.2) | 39 (92.9) | |||
| Prematurity | 2.27 | 0.76-6.73 | 0.138 | |||
| Yes | 22 (34.9) | 10 (47.6) | 12 (28.6) | |||
| No | 41 (65.1) | 11 (52.4) | 30 (71.4) | |||
| CSF abnormality | ||||||
| Protein (> 150 mg/dL) | 9 (42.8) | 9 (42.8) | 0 | |||
| Leukocytes (> 25 white blood cells/mm 3 ) | 6 (28.6) | 6 (28.6) | 0 | |||
| Reagent VDRL | 6 (28.6) | 6 (28.6) | 0 |